Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring

Bacteremia and ventilator-associated pneumonia due to a pan-resistant <i>Klebsiella pneumoniae</i> strain co-producing KPC and OXA-48 carbapenemases was successfully treated in a COVID-19 critically ill patient with a combination therapy of a high-dose continuous infusion of meropenem (u...

Full description

Bibliographic Details
Main Authors: Pier Giorgio Cojutti, Giacomo Fornaro, Milo Gatti, Matteo Rinaldi, Paolo Gaibani, Maddalena Giannella, Federico Pea, Pierluigi Viale
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Infectious Disease Reports
Subjects:
continuous infusion of meropenem
therapeutic drug monitoring
critically ill patient
Online Access:https://www.mdpi.com/2036-7449/14/1/10

Internet

https://www.mdpi.com/2036-7449/14/1/10

Similar Items